Pomalidomide-5-O-CH3 is primarily utilized in the field of medical research, particularly in the development of novel therapeutic agents. Its application is focused on the study of its potential efficacy in treating certain types of cancers, especially multiple myeloma. Researchers investigate its ability to modulate the immune system and inhibit the growth of malignant cells. Additionally, it is explored for its anti-inflammatory properties, which could be beneficial in managing autoimmune disorders. The compound is also used in preclinical studies to understand its pharmacokinetics and pharmacodynamics, aiding in the optimization of drug formulations for enhanced therapeutic outcomes.